InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hoekman John, Directeur Scientifique. Director active across 1 companies, notably Impel Neuropharma INC. In total, 4 disclosures have been logged. The latest transaction was filed on 22 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€29,05920,000 shares@ €1.4529100.0% of flow
Common Stock
SEC:0001209191-21-071087·
€29,05920,000 shares@ €1.452950.0% of flow
Common Stock
SEC:0001209191-21-071087:0·
04,253 shares0
Common Stock
SEC:0001209191-21-038665·
04,253 shares0
Common Stock
SEC:0001209191-21-038665:0·
4 of 4 declarations
About Hoekman John
John Hoekman is the Chief Scientific Officer at IMPEL NEUROPHARMA INC. He is responsible for leading research and development initiatives. Hoekman plays a crucial role in innovation and the development of new products.
